Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Anxiety disorders are characterized by widespread and persistent anxiety or recurrent panic attacks. As a result of their high prevalence, chronicity, and comorbidity, patients’ quality of life and functioning are severely compromised. However, several patients do not receive treatment. Areas covered: This review discusses the effectiveness, safety, and limitations of major medications and cognitive bias modification (CBM) for treating anxiety disorders. The possibility of combined treatment is also discussed in the literature. Furthermore, drawing on Chinese cultural perspectives, the authors suggest that anxiety can be recognized, measured, and coped with at three levels of skill (技), vision (术), and Tao (道). Expert opinion: The combination of pharmacotherapy and CBM is possibly more effective in treating anxiety disorders than either treatment alone. However, clinicians and patients should participate in the joint decision-making process and consider comprehensive factors. Moderate anxiety has adaptive significance. In the coming years, by combining the downward analytical system of western culture with the upward integrative system of Chinese culture, a comprehensive understanding of anxiety and anxiety disorders should be established, rather than focusing only on their treatment.

Cite

CITATION STYLE

APA

Kong, Q., & Han, B. (2024). Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders. Expert Review of Neurotherapeutics. Taylor and Francis Ltd. https://doi.org/10.1080/14737175.2024.2334847

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free